2015 has been a year full of important judgments in the field of medicinal products. This article aims to explain the most important decisions in order to give the reader a perspective on developments and clarifications that have been incorporated into the regulation of medicinal products through recent case law in Spanish and European courts.
In order to do this, we have grouped the decisions of the courts according to their topic, starting our tour through the regulation of pharmaceutical warehouses, and continuing to the important decisions on the contributions related to sales by the pharmaceutical companies, the regulation of the so-called “sunset clause”, data exclusivity, the definition of medicinal products or its assessment. We continue our journey analyzing the constant changes in public financing, the prescribing and dispensing medicinal products, the pharmaceutical provision, reference prices and homogeneous groupings. Finally, we end our publication with a comment on two important decisions regarding public procurement and a European reference to the regulation of orphan medicinal products.